Profil
Rosh Chandraratna is the founder of Io Therapeutics, Inc. Former positions include Director & Chief Scientific Officer at NuRx Pharmaceuticals, Inc. from 2007 to 2009, Vice President-Retinoid Research at Allergan, Inc. in 2004, Senior Vice President-Research & Development at Vitae Pharmaceuticals LLC from 2004 to 2006, and Senior Vice President-Research & Development at Acucela, Inc. from 2006 to 2007.
Ehemalige bekannte Positionen von Rosh Chandraratna
| Unternehmen | Position | Ende |
|---|---|---|
| NURX PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 03.10.2009 |
| ACUCELA INC | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2007 |
| VITAE PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2006 |
| ALLERGAN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2004 |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
NuRx Pharmaceuticals, Inc.
NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















